Effects of arzoxifene on bone, lipid markers, and safety parameters in postmenopausal women with low bone mass. [electronic resource]
Producer: 20110418Description: 1215-26 p. digitalISSN:- 1433-2965
- Aged
- Biomarkers -- blood
- Bone Density -- drug effects
- Bone Density Conservation Agents -- administration & dosage
- Bone Remodeling -- drug effects
- Dose-Response Relationship, Drug
- Double-Blind Method
- Endometrium -- drug effects
- Female
- Humans
- Lipids -- blood
- Middle Aged
- Osteoporosis, Postmenopausal -- blood
- Piperidines -- administration & dosage
- Raloxifene Hydrochloride -- therapeutic use
- Selective Estrogen Receptor Modulators -- administration & dosage
- Thiophenes -- administration & dosage
- Vasomotor System -- drug effects
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.